CNE000000G05
CNE000000G05
HPGC RENMINTONGTAI PHARMACEUTIC
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 5.52B EUR | 4.5B EUR | 5.91B EUR | 6.27B EUR |
Enterprise Value | 5.53B EUR | 4.51B EUR | 5.78B EUR | 5.77B EUR |
Valuation Multiples | ||||
Trailing P/E | 38.08x | 43.7x | 60.81x | 66.3x |
Forward P/E | 15.87x | -- | -- | -- |
Price to Sales | 0.52x | 0.57x | 0.75x | 0.82x |
Price to Book | 1.78x | 1.45x | 1.93x | 2.08x |
EV/Revenue | 0.52x | 0.57x | 0.74x | 0.75x |
EV/EBITDA | 21.5x | 23.05x | 28.16x | 29.67x |
Price to FCF (P/FCF) | -- | 25.7x | 13.43x | 13.15x |
EV/FCF | -- | 25.74x | 13.14x | 12.09x |
FCF Yield | -0.47% | 3.89% | 7.44% | 7.61% |